By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.

Would you give one breath if you could detect lung cancer and other diseases?

Introducing OneBreath™

A unique technology platform developed by Breath Diagnostics to quantitatively analyze organic compounds in a single breath to detect lung cancer and other diseases.1

Our highly portable system will be readily available to patients through medical providers.1

In contrast to a Low-Dose CT Scan, OneBreath is a quicker and easier way of lung cancer diagnosis. We are currently enrolling patients for our 2nd generation system Pilot Study.

Breath Collection

Patients provide one complete breath via a unique collection system in less than 30 seconds.

Breath Processing and Analysis

In a simple automated process, the OneBreath™ micro-reactor captures the organic compounds contained in the breath. Once captured, the samples is analyzed in our laboratories.

Get Results

Results will be available within 3-4 business days.

Why OneBreath™?

OneBreath™ provides a safe, convenient, and inexpensive way to identify lung cancer in at risk patients, before they know they have a problem.1

Accurate Results

OneBreath™ detects lung cancer with fewer false positives and higher specificity than a low-dose CT scan.

Accessible

The OneBreath™ system increases access to potentially life-saving lung cancer screenings by being portable enough for use in a physician's office or local pharmacy.

Affordable

The OneBreath™ technology platform demonstrates a lower false positive rate versus CT scans, reducing the number of unnecessary follow-up diagnostic procedures.

Easy to Use

The simplicity of the OneBreath™ system provides the potential to enhance screening compliance due to the fact that only a single breath is required.

Research & Publications

Who's Afraid of Early Cancer Detection
Grail seeks FDA approval for its Galleri test, which can detect tumors long before symptoms develop. But critics worry that the costs are too high.
News
February 4, 2024
New Report: Critically Low Lung Cancer Screening Rates Reveal Opportunity to Save More Lives
American Lung Association’s report examines toll of lung cancer state-by-state, underscores urgent need for more people to be screened
News
November 15, 2022

News & Blog Posts

Who's Afraid of Early Cancer Detection
Grail seeks FDA approval for its Galleri test, which can detect tumors long before symptoms develop. But critics worry that the costs are too high.
News
February 4, 2024
New Report: Critically Low Lung Cancer Screening Rates Reveal Opportunity to Save More Lives
American Lung Association’s report examines toll of lung cancer state-by-state, underscores urgent need for more people to be screened
News
November 15, 2022

Testimonials

To the promise of breath based lung cancer diagnostics and what Breath diagnostics could offer patients
"Technology like OneBreath has so much potential for improving and saving lives."
Dr. Kevin Gardner
Executive VP Research and Innovation, University of Louisville
arrow
arrow
OneBreath™ by Breath Diagnostics

OneBreath™ may save your life.

Contact us to discover the future of lung cancer screening or click below to learn more.1